KGKonstantinos Grapatsas

Konstantinos Grapatsas

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Konstantinos Grapatsas has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Solitary fibrous tumor of the lung: diagnostic challenges and surgical management

    by Vasileios Leivaditis, Konstantinos Grapatsas, Francesk Mulita, Sofoklis Mitsos, Efstratios Koletsis, Athanasios Papatriantafyllou, Elias Liolis, Admir Mulita, Periklis Tomos, Manfred Dahm

    Solitary fibrous tumors (SFTs) are rare mesenchymal neoplasms that typically arise from the pleura but may occur in various extrathoracic sites. Primary intraparenchymal pulmonary SFTs without pleural attachment are exceptionally uncommon and often pose diagnostic and therapeutic challenges. We report the case of a middle-aged female patient presenting with progressive dyspnea and a large mass in the left lower lobe on imaging. Computed tomography revealed a well-circumscribed, hypervascular mass occupying the left lower lobe. Bronchoscopic and percutaneous biopsies were nondiagnostic, and surgical resection was pursued. Intraoperatively, the tumor was found to arise from the lung parenchyma without pleural involvement. Histopathological examination demonstrated a spindle-cell neoplasm with the typical “patternless pattern,” and immunohistochemistry confirmed nuclear STAT6 positivity, establishing the diagnosis of SFT. The postoperative course was uneventful apart from a transient pulmonary embolism, which was successfully treated. The patient was discharged in good condition and is under regular radiologic surveillance. SFTs of the lung are rare and often mimic more common pulmonary tumors radiologically. Histologic confirmation with STAT6 immunohistochemistry is crucial for accurate diagnosis. Complete surgical excision remains the mainstay of treatment. Given the risk of late recurrence—especially in large tumors—long-term imaging follow-up is mandatory. This case highlights the importance of considering SFT in the differential diagnosis of large pulmonary masses, the critical role of STAT6-based histopathologic confirmation, and the necessity for prolonged surveillance even after complete resection.


  • Massive right intrathoracic liver herniation four years after traumatic diaphragmatic rupture

    by Vasileios Leivaditis, Athanasios Papatriantafyllou, Benjamin Ehle, Michail Galanis, Efstratios Koletsis, Francesk Mulita, Manfred Dahm, Vasileios Lozos, Konstantinos Grapatsas

    Diaphragmatic hernias following severe thoracoabdominal injuries are infrequent clinical occurrences, and right-sided post-traumatic hernias are particularly rare due to the protective barrier provided by the liver. The overall incidence of diaphragmatic rupture following trauma is approximately 1.3%, with only 20% of these cases identified on the right side. This report aims to present the case of a patient diagnosed with a substantial intrathoracic liver hernia 4 years after a traumatic incident. Surgical intervention successfully corrected the diaphragmatic defect, and the patient’s postoperative course was uneventful. A 2-month follow-up revealed no signs of recurrence, underscoring the effectiveness of the surgical approach in managing this unusual presentation of diaphragmatic hernia.

  • Thoracoscopic treatment of recurrent catamenial pneumothorax

    by Vasileios Leivaditis, Athanasios Papatriantafyllou, Konstantinos Grapatsas, Efstratios Koletsis, Nikolaos Charokopos, Francesk Mulita, Ioannis Panagiotopoulos, Manfred Dahm

    Introduction: Catamenial pneumothorax is a rare but potentially life-threatening condition that affects women of reproductive age. It is characterized by the recurrent occurrence of pneumothorax during or around the menstrual period. The pathophysiology of catamenial pneumothorax is not well understood, but is thought to be related to the presence of endometrial tissue in the pleural cavity. Case Presentation: A 42-year-old woman was referred to our outpatient department for further thoracic surgical treatment. She already had two previous episodes of pneumothorax that occurred during her menstrual period. A chest X-ray revealed a right-sided pneumothorax and she was admitted to the hospital where a chest tube was placed to treat the pneumothorax. CT scan revealed the presence of endometrial tissue under the right diaphragm. The patient underwent a total laparoscopic hysterectomy to remove the source of endometrial tissue. The subdiaphragmatic endometrial tissue was also removed. She subsequently underwent thoracoscopic treatment to treat the pneumothorax. Conclusion: The aim of this study was to review the clinical features, diagnostic criteria, and treatment options for catamenial pneumothorax. In addition, the study highlights the importance of a multidisciplinary approach to the management of catamenial pneumothorax, involving pulmonologists, gynecologists, and thoracic surgeons. Further studies are needed to optimize the management of this rare condition.

  • The Dose-Dependent Cardioprotective Effect of Levosimendan against Ischemia/Reperfusion Injury in an Isolated Rat Heart Experimental Model

    by V. Leivaditis, E. Koletsis, K. Grapatsas, D. Dougenis, M. Dahm

    Background: This study aims to investigate the dose-dependent effect of levosimendan in an experimental model of ischemia–reperfusion injury in isolated rat hearts. Method: The Langendorff's isolated heart perfusion model was used. The isolated rat hearts underwent 30 minutes of perfusion, a 30-minute period of regional ischemia, and a 120-minute period of reperfusion. Animals were randomly divided into eight experimental groups of nine animals in each group: (1) control, (2) sham, (3) digox (negative control, digoxin of 1.67 μg/min), (4) levo 1 (levosimendan: 0.01 μg/min), (5) levo 2 (levosimendan: 0.03 μg/mL), (6) levo 3 (levosimendan: 0.1 μg/min), (7) levo 4 (levosimendan: 0.3 μg/min), (8) levo 5 (levosimendan: 1 μg/min). Hemodynamic parameters were recorded throughout the experiment. Occurrence of arrhythmias and coronary flow were also studied. At the end of every experiment, the infarct size was measured and evaluated. Markers of myocardial injury were also recorded. Finally, reactive oxygen species were measured. Results: A dose-dependent improvement of the hemodynamic response was observed after the administration of levosimendan in various concentrations. Levosimendan offered a significant increase of the coronary flow and a reduction of arrhythmias. A dose-dependent reduction of the size of myocardial infarction, myocardial injury was also demonstrated. Conclusion: The administration of levosimendan offers a significant improvement in the hemodynamic response of isolated hearts, an increase of the coronary flow, and a significant reduction of the occurrence of arrhythmias, of the size of myocardial infarction and oxidative stress in isolated rat hearts. Article published online: 28 January 2023 © 2023. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

  • Open Access

    Cavernous hemangioma of the left atrium: A rare tumor

    by Christophoros Kotoulas, Charalampos Georgiou, Konstantinos Grapatsas, Sotirios Kotoulas, Nikolaos Theodosiadis, Ioannis Panagiotou